Antiangiogenic therapy for primary and metastatic brain tumors Review uri icon

Overview

MeSH Major

  • Angiogenesis Inhibitors
  • Brain Neoplasms

abstract

  • We first provide the theoretic foundation of antiangiogenic therapy by describing the biology of angiogenesis as it applies to brain tumors. We then outline experimental antiangiogenic therapies that are being applied preclinically to brain tumors, as well as published clinical trial data and ongoing clinical trials in patients. Primary and metastatic brain tumors are covered, although there is far less exploration in the literature of brain metastases.

publication date

  • October 2004

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.hoc.2004.05.003

PubMed ID

  • 15474340

Additional Document Info

start page

  • 1161

end page

  • 81, x

volume

  • 18

number

  • 5